主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SEER
#3273
Seer, Inc. Class A Common Stock
1.7
2
-16.50%
版块:
基础:
利润货币:
日范围
年范围
日变化
-16.50%
每月变动
-9.47%
6个月变化
-16.50%
年变化
-20.74%
前一天收盘价
2.0
6
Open
1.7
2
Bid
Ask
Low
1.7
2
High
1.7
2
交易量
15
市场
股票
医疗保健
SEER
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
54.92 M
55.74 M
54.82 M
52.29 M
51.76 M
—
Valuation ratios
Enterprise value
310.87 M
373.54 M
246.02 M
323.77 M
318.21 M
1.26 B
Price to earnings ratio
-1.53
-1.66
-1.2
-1.54
-1.6
-6
Price to sales ratio
8.55
10.16
6.8
7.91
7.81
32.69
Price to cash flow ratio
2.78
3.12
2.22
2.49
2.85
10.68
Price to book ratio
0.08
0.44
0.08
0.1
0.11
0.73
Enterprise value to EBITDA ratio
-3.85
-4.41
-3.03
-4.34
-4.56
-16.35
Profitability ratios
Return on assets %
0.06
0.06
0.06
0.06
0.06
0.24
Return on equity %
0.06
0.07
0.06
0.07
0.07
0.26
Return on invested capital %
—
76.16
75.02
81.19
75.75
308.12
Gross margin %
48.07
50.63
49.01
52.11
51.2
202.95
Operating margin %
603.3
587.2
493.01
506.79
469.45
2 056.45
EBITDA margin %
-509.62
-494.65
-390.7
-438.63
-382.09
-1 706.08
Net margin %
528.97
543.55
474.39
479.49
442.47
1 939.89
Liquidity ratios
Quick ratio
17.88
16.04
18.81
18.51
13.71
67.07
Current ratio
18.36
16.53
19.34
19.15
14.25
69.27
Inventory turnover
0.01
0.01
0
0.01
0
0.02
Asset turnover
0.01
0.01
0.01
0.01
0.01
0.05
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.23
0.18
0.19
0.25
0.13
0.76
EBIT per share
-0.4
-0.38
-0.35
-0.35
-0.33
-1.41
EBITDA per share
-0.34
-0.32
-0.28
-0.3
-0.27
-1.17
Total debt per share
—
—
—
—
—
—
Cash per share
4.05
4.8
4.8
4.48
4.34
18.42
Net current asset value per share
4.32
4.06
4.3
3.84
3.7
15.9
Tangible book value per share
5.63
5.25
5.24
4.96
4.83
20.28
Working capital per share
4.08
3.82
4.07
3.64
3.44
14.97
Book value per share
5.63
5.25
5.24
4.91
4.69
20.09
Seer Inc - Class A
Seer, Inc. is an American biotechnology company headquartered in Redwood City, California. Established in 2017, the company develops technologies for proteomics research.
新闻
Seer, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:SEER) 2026-02-27
Seer, Inc. (SEER) Q4 2025 Earnings Call Transcript
Seer apresenta crescimento de 67% na base instalada, mas receita decepciona
Seer Q4 2025 slides: installed base surges 67%, revenue misses mark
Lucro da Seer superou projeções por $0,02; receita menor do que estimativas
Seer earnings beat by $0.02, revenue fell short of estimates
Seer apresentará tecnologia de proteômica em conferência nos EUA
Seer to showcase proteomics technology at US HUPO conference
Mass spectrometry study validates protein-gene associations for drug discovery
Seer, Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:SEER) 2025-11-26
Seer no Fórum CG MedTech: inovações em proteômica lideram o caminho
Seer at CG MedTech Forum: Proteomics Innovations Lead the Way